Speaking of ESS, it was Dr. Joe that brought the

New Post Public Reply Private Reply Replies (0) Message Board
redspeed jamiejaytrader #25627
459
Speaking of ESS, it was Dr. Joe that brought the opportunity to the company. It was tied up in over a billion dollar lawsuit and he stepped in along with AMBS to settle it. I guess he could have done it being on the BOD of Regenicin or even started his own company and done it.

Why did he do what he did? One (me) would believe Dr. Joe saw the potential of Amarantus with MANF as being one of the first regenerative medicine companies.

Quote:
"I believe in MANF," said Dr. Rubinfeld, "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. The fundamental scientific premise of reducing protein misfolding is basic, yet very profound. The data, while early, demonstrates very clearly at the cellular level and in animals that MANF reduces apoptosis, improves cellular function, and restores behavioural deficits in a number of disease models, including Parkinson's, Stroke, Myocardial Infarction and Traumatic Brain Injury. These are all indications with very large markets and clear unmet medical need. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug ."



You can see how his relationship with Amarantus and Dr. John Commisiong developed over the years from advisor to BOD to helping work out a deal of a product he believed in. Keep in mind it's not like Dr. Joe was sitting on 20 boards over the last 5 years and I'm sure 500 other companies would have loved his collaboration.

Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
Aug 25, 2010
https://www.fiercebiotech.com/biotech/regenic...-directors

Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
NOVEMBER 06, 2012
https://www.amarantus.com/news/press-releases...-dr-joseph

Amarantus Appoints Renowned Drug Development Expert and Co-Founder of Amgen, Joseph Rubinfeld, Ph.D., to Its Board of Directors
December 08, 2014
http://globenewswire.com/news-release/2014/12...ml?print=1

Amarantus Completes Acquisition of ESS From Lonza for the Treatment of Severe Burns
JULY 15, 2015
https://www.amarantus.com/news/press-releases...za-for-the

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

P.C. Richard & Son's Generations+: Loyalty Rewarded

Updated Category News Views 60

What's the Deal with Generations+ at P.C. Richard & Son? Felt like companies were giving away the farm just to keep customers hooked, and then I heard about P.C. Richard & Son's latest play. They've been around for a scorching 117 years, and now they're offering something they've never done before: a free membership program called Generations+ that tosses perks like candy...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 75

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading
Solid Case for Agent Continuity in Real Estate

Updated Category News Views 0

A Singular Approach in Real Estate When it comes to real estate, you'd think having a small army of professionals working on a deal might cover all bases and make life easier. But according to Real Estate Expert Natalie Breland Wiggins, that's exactly where things might go sideways. She lays it out in a HelloNation article, saying that one good ol' reliable real estate...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 86

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 136

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
BVB, SPORTFIVE Lock Partnership Until 2034; Sparks Fly

Updated Category News Views 90

Sealing the Deal with Strategic Long-term Goals Alright, here’s the scoop straight outta Dortmund. Borussia Dortmund and SPORTFIVE have penned themselves a cushy deal lasting till 2034. That’s right—eight more solid years. Talk about shuffling the deck with some planning foresight, huh? Been hitting shoulders since '99, these two, so this ain’t just another...

Continue Reading
Freedom Bank Taps McIntyre as CRE Powerhouse Leader

Updated Category News Views 77

Dan McIntyre's latest move to Freedom Bank of Virginia as Senior Vice President screams strategy. This isn’t just another shuffle of executive chairs—it’s a calculated play to deepen their roots in the fiercely competitive Washington D.C. real estate market. Now, why should investors like you sit up and take notice? Well, when a bank with hefty capital and a yawning...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 109

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Paris vs. Berlin: Europe's Urban Driving Chaos Revealed

Updated Category News Views 103

Paris in the Fast Lane to Danger Paris, the city of love, is also the city of reckless acceleration if you peek at Geotab’s data. The City of Light isn’t just known for its romance and baguettes anymore; it’s got quite a knack for harsh driving events—1,191 per 1,000 trips, to be precise. That's a mind-boggling 5.3 times more than Berlin, the sensible sibling. A...

Continue Reading
Midterm Election Insights: Border Enforcement Debate Heats Up

Updated Category News Views 139

The Midterm Aftermath: What Really Matters So the ballots are counted, and once again, the shiny chatter about midterms seemed to orbit more around wallet aches and foreign skirmishes than dusty border control debates. But, dig a bit deeper—like poking at a sore spot—and you'll find border security sitting patiently in the wings. Not gone, just waiting for its...

Continue Reading

Top 5 Most Recently Viewed Articles

Shareholder Rights in AFBI, BLD, and NSA Deals

Updated Category News Views 4

When it comes to mergers and acquisitions, sometimes it feels like regular folks are fighting uphill battles just to get a fair shake. This time, we've got Affinity Bancshares, TopBuild Corp., and National Storage Affiliates Trust on the chopping block, and Halper Sadeh LLC is raising the flag about potential shenanigans. If you're holding any stock in these companies or...

Continue Reading
Golar LNG Limited Prepares for Upcoming Annual Meeting

Updated Category News Views 207

Golar LNG Limited Announces Upcoming Annual General Meeting Golar LNG Limited has exciting news for its shareholders regarding the upcoming Annual General Meeting, scheduled for a Tuesday in May. The organization is eager to connect with its stakeholders, providing valuable insights and updates on its operational initiatives. Important Voting Information The record date...

Continue Reading
Spreedly Merges Payment Solutions with Enhanced Fraud Prevention

Updated Category News Views 185

Spreedly Merges Payment Solutions with Enhanced Fraud Prevention Spreedly, a prominent open payments platform, recently made headlines with its strategic acquisition of Dodgeball. This move underscores Spreedly's commitment to integrating payment optimization with robust fraud prevention measures. As digital transactions continue to escalate, ensuring security while...

Continue Reading
AbbVie Faces $3.5 Billion Impairment Charge on Drug Asset

Updated Category News Views 242

AbbVie Announces Significant Impairment Charge AbbVie (NYSE: ABBV) recently revealed its intention to record a considerable non-cash after-tax impairment charge of approximately $3.5 billion. This decision pertains specifically to the emraclidine asset, a drug under development targeting conditions such as schizophrenia and Alzheimer’s disease. Understanding Emraclidine...

Continue Reading
OutKick Experiences Unprecedented Social Media Growth

Updated Category News Views 120

OutKick’s Remarkable Social Media Growth OutKick has witnessed a tremendous surge in its social media engagement, concluding January with a staggering 1.6 million social actions across platforms such as Facebook, X (formerly Twitter), and Instagram. This represents a notable 65% increase compared to the previous month. Additionally, the platform saw a phenomenal rise in...

Continue Reading